Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 2
1982 3
1983 1
1987 2
1988 2
1989 1
1990 3
1991 7
1993 6
1994 3
1995 11
1996 2
1997 3
1998 6
1999 6
2000 9
2001 7
2002 5
2003 6
2004 6
2005 5
2006 5
2007 5
2008 8
2009 7
2010 5
2011 7
2012 16
2013 12
2014 10
2015 10
2016 5
2017 11
2018 9
2019 4
2020 7
2021 14
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

227 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease.
Potter H, Woodcock JH, Boyd TD, Coughlan CM, O'Shaughnessy JR, Borges MT, Thaker AA, Raj BA, Adamszuk K, Scott D, Adame V, Anton P, Chial HJ, Gray H, Daniels J, Stocker ME, Sillau SH. Potter H, et al. Among authors: anton p. Alzheimers Dement (N Y). 2021 Mar 24;7(1):e12158. doi: 10.1002/trc2.12158. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 33778150 Free PMC article.
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer.
Gris-Oliver A, Ibrahim YH, Rivas MA, García-García C, Sánchez-Guixé M, Ruiz-Pace F, Viaplana C, Pérez-García JM, Llombart-Cussac A, Grueso J, Parés M, Guzmán M, Rodríguez O, Anton P, Cozar P, Calvo MT, Bruna A, Arribas J, Caldas C, Dienstmann R, Nuciforo P, Oliveira M, Cortés J, Serra V. Gris-Oliver A, et al. Among authors: anton p. Br J Cancer. 2021 Apr;124(9):1581-1591. doi: 10.1038/s41416-021-01293-1. Epub 2021 Mar 15. Br J Cancer. 2021. PMID: 33723394 Free PMC article.
227 results